We have observed
10 EP applications
Raymond Stevenson Gairns
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after March 23, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
METHODS AND COMPOSITIONS FOR TREATING, REVERSING, INHIBITING OR PREVENTING RESISTANCE TO ANTIPLATELET THERAPY
COMBINATION TREATMENT OF CANCER
HETEROBICYCLIC COMPOUNDS AS BETA-LACTAMASE INHIBITORS
Certain triazolopyrazines, compositions thereof and methods of use therefor
CRYSTALLINE FORMS OF (S) -4-AMINO-N- (1- (4 - CHLOROPHENYL) - 3 - HYDROXYPROPYL) -1- (7H - PYRROLO [2, 3-D]PYRIMIDI N-4-YL) PIPERIDINE-4-CARBOXAMIDE
PHARMACEUTICAL FORMULATION OF N- [5- [2-(3,5-DIMETHOXYPHENYL) ETHYL]-2H-PYRAZOL-3-YL]-4-[(3R,5S)-3,5-DIMETHYLPIPERAZIN-1-YL]BENZAMIDE
CERTAIN TRIAZOLOPYRIDINES, COMPOSITIONS THEREOF AND THEIR USE IN THE TREATMENT OF CANCER.
IMIDAZO[4,5-C]QUINOLIN-1-YL DERIVATIVE USEFUL IN THERAPY
METHOD FOR SUPPRESSING GLUCAGON SECRETION OF AN SGLT2 INHIBITOR